Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Pediapharm receives Health Canada approval for Rupatadine

July 21 (Reuters) - Pediapharm Inc: 
    * Pediapharm receives health Canada approval for Rupatadine 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCCN607qCp 
Further company coverage:  PDP.V  
 
 (Bengaluru Newsroom: +1-646-223-8780)

Recent news on Medexus Pharmaceuticals

See all news